News from ESC 2024: Predicting 30-year CV outcomes in women

Paul Ridker at ESC 2024

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Continuation or interruption of OAC during TAVI?
Continuation or interruption of OAC during TAVI?
ESC Congress 2024
Continuation or interruption of OAC during TAVI?
- Dirk Jan van Ginkel, MD
Effects of empagliflozin on cardiac remodeling post-MI
Effects of empagliflozin on cardiac remodeling post-MI
ESC Congress 2024
Effects of empagliflozin on cardiac remodeling post-MI
- Jaclyn Carberry, MD
Beneficial effects of MRAs in HF across the LVEF spectrum
Beneficial effects of MRAs in HF across the LVEF spectrum
ESC Congress 2024
Beneficial effects of MRAs in HF across the LVEF spectrum
- Pardeep Jhund, MD, PhD
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
ESC Congress 2024
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
- Scott Solomon, MD